The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow.
Ingram W, Lea NC, Cervera J, Germing U, Fenaux P, Cassinat B, Kiladjian JJ, Varkonyi J, Antunovic P, Westwood NB, Arno MJ, Mohamedali A, Gaken J, Kontou T, Czepulkowski BH, Twine NA, Tamaska J, Csomer J, Benedek S, Gattermann N, Zipperer E, Giagounidis A, Garcia-Casado Z, Sanz G, Mufti GJ.
Ingram W, et al. Among authors: tamaska j.
Leukemia. 2006 Jul;20(7):1319-21. doi: 10.1038/sj.leu.2404215. Epub 2006 Apr 13.
Leukemia. 2006.
PMID: 16617322
No abstract available.